2023-2029 Global Viral Vector and Vaccine Industry Research & Trends Analysis Report
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for Viral Vector and Vaccine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Viral Vector and Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Viral Vector and Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Adenovirus segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Research Institutes has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Viral Vector and Vaccine include ABL, Addgene, Aldevron, Boehringer Ingelheim International GmbH, Brammer Bio, Charles River Laboratories, Creative-Biogene, Fujifilm Corporation and General Electric, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Viral Vector and Vaccine. Report Highlights:
(1) Global Viral Vector and Vaccine market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Viral Vector and Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Viral Vector and Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Viral Vector and Vaccine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Viral Vector and Vaccine segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Viral Vector and Vaccine, capacity, production and trends.
(7) Viral Vector and Vaccine industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
Market segment by application, can be divided into
Research Institutes
Biopharmaceutical Companies
Others
Market segment by players, this report covers
ABL
Addgene
Aldevron
Boehringer Ingelheim International GmbH
Brammer Bio
Charles River Laboratories
Creative-Biogene
Fujifilm Corporation
General Electric
MerckKGaA
Novasep
Pfizer
Spark Therapeutics
Thermo Fisher Scientific
Waisman Biomanufacturing
1 Market Overview
1.1 Viral Vector and Vaccine Definition
1.2 Global Viral Vector and Vaccine Market Size and Forecast
1.2.1 By Revenue, Global Viral Vector and Vaccine Market Size, 2018-2029
1.2.2 By Sales Volume, Global Viral Vector and Vaccine Market Size, 2018-2029
1.2.3 Global Viral Vector and Vaccine Price Trend, 2018-2029
1.3 China Viral Vector and Vaccine Market Size and Forecast
1.3.1 By Revenue, China Viral Vector and Vaccine Market Size, 2018-2029
1.3.2 By Sales Volume, China Viral Vector and Vaccine Market Size, 2018-2029
1.3.3 China Viral Vector and Vaccine Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Viral Vector and Vaccine Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Viral Vector and Vaccine Share in Global Market, 2018-2029
1.4.3 Viral Vector and Vaccine Market Size: China VS Global, 2018-2029
1.5 Viral Vector and Vaccine Market Dynamics
1.5.1 Viral Vector and Vaccine Market Drivers
1.5.2 Viral Vector and Vaccine Market Restraints
1.5.3 Viral Vector and Vaccine Industry Trends
1.5.4 Viral Vector and Vaccine Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Viral Vector and Vaccine Revenue by Company, 2018-2023
2.2 Global Viral Vector and Vaccine Sales Volume by Company, 2018-2023
2.3 Global Viral Vector and Vaccine Price by Company, 2018-2023
2.4 Global Viral Vector and Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Viral Vector and Vaccine Concentration Ratio
2.6 Global Viral Vector and Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Viral Vector and Vaccine Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Viral Vector and Vaccine Revenue by Company, 2018-2023
3.2 China Viral Vector and Vaccine Sales Volume by Company, 2018-2023
3.3 China Viral Vector and Vaccine Viral Vector and Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Viral Vector and Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Viral Vector and Vaccine Domestic VS Export
3.6 China Market, Viral Vector and Vaccine Import & Export
3.6.1 China Market, Viral Vector and Vaccine Import & Export, 2018-2029
3.6.2 China Viral Vector and Vaccine Import & Export Trends
3.6.3 Main Sources of China Viral Vector and Vaccine Import
3.6.4 Export Destination of China Viral Vector and Vaccine
4 Viral Vector and Vaccine Production by Region
4.1 Global Viral Vector and Vaccine Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Viral Vector and Vaccine Manufacturers
4.3 Global Major Manufacturers, Viral Vector and Vaccine Capacity Expansion and Future Plans
4.4 Global Viral Vector and Vaccine Capacity by Region
4.5 Global Viral Vector and Vaccine Production by Region
4.5.1 Global Viral Vector and Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Viral Vector and Vaccine Production by Region, 2018-2023
4.5.3 Global Viral Vector and Vaccine Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Viral Vector and Vaccine Industry Chain
5.2 Viral Vector and Vaccine Upstream Analysis
5.2.1 Viral Vector and Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Viral Vector and Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Viral Vector and Vaccine Production Mode
5.6 Viral Vector and Vaccine Procurement Model
5.7 Viral Vector and Vaccine Industry Sales Model and Sales Channels
5.7.1 Viral Vector and Vaccine Sales Model
5.7.2 Viral Vector and Vaccine Typical Distributors
6 Sights by Type
6.1 Viral Vector and Vaccine Classification
6.1.1 Adenovirus
6.1.2 Fowlpox Virus
6.1.3 Attenuated Yellow Fever
6.1.4 Vaccinia Virus Vectors
6.2 By Type, Global Viral Vector and Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Viral Vector and Vaccine Revenue, 2018-2029
6.4 By Type, Global Viral Vector and Vaccine Sales Volume, 2018-2029
6.5 By Type, Global Viral Vector and Vaccine Price, 2018-2029
7 Sights by Application
7.1 Viral Vector and Vaccine Segment by Application
7.1.1 Research Institutes
7.1.2 Biopharmaceutical Companies
7.1.3 Others
7.2 By Application, Global Viral Vector and Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Viral Vector and Vaccine Revenue, 2018-2029
7.4 By Application, Global Viral Vector and Vaccine Sales Volume, 2018-2029
7.5 By Application, Global Viral Vector and Vaccine Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Viral Vector and Vaccine Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Viral Vector and Vaccine Revenue, 2018-2029
8.3 By Region, Global Viral Vector and Vaccine Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Viral Vector and Vaccine Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Viral Vector and Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Viral Vector and Vaccine Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Viral Vector and Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Viral Vector and Vaccine Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Viral Vector and Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Viral Vector and Vaccine Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Viral Vector and Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Viral Vector and Vaccine Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Viral Vector and Vaccine Revenue, 2018-2029
9.3 By Country, Global Viral Vector and Vaccine Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Viral Vector and Vaccine Market Size, 2018-2029
9.4.2 By Company, U.S. Viral Vector and Vaccine Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Viral Vector and Vaccine Market Size, 2018-2029
9.5.2 By Company, Europe Viral Vector and Vaccine Sales Volume Market Share, 2022
9.5.3 By Type, Europe Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Viral Vector and Vaccine Market Size, 2018-2029
9.6.2 By Company, China Viral Vector and Vaccine Sales Volume Market Share, 2022
9.6.3 By Type, China Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Viral Vector and Vaccine Market Size, 2018-2029
9.7.2 By Company, Japan Viral Vector and Vaccine Sales Volume Market Share, 2022
9.7.3 By Type, Japan Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Viral Vector and Vaccine Market Size, 2018-2029
9.8.2 By Company, South Korea Viral Vector and Vaccine Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Viral Vector and Vaccine Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Viral Vector and Vaccine Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Viral Vector and Vaccine Market Size, 2018-2029
9.10.2 By Company, India Viral Vector and Vaccine Sales Volume Market Share, 2022
9.10.3 By Type, India Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Viral Vector and Vaccine Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Viral Vector and Vaccine Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Viral Vector and Vaccine Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 ABL
10.1.1 ABL Company Information, Head Office, Market Area and Industry Position
10.1.2 ABL Viral Vector and Vaccine Models, Specifications and Application
10.1.3 ABL Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 ABL Company Profile and Main Business
10.1.5 ABL Recent Developments
10.2 Addgene
10.2.1 Addgene Company Information, Head Office, Market Area and Industry Position
10.2.2 Addgene Viral Vector and Vaccine Models, Specifications and Application
10.2.3 Addgene Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Addgene Company Profile and Main Business
10.2.5 Addgene Recent Developments
10.3 Aldevron
10.3.1 Aldevron Company Information, Head Office, Market Area and Industry Position
10.3.2 Aldevron Viral Vector and Vaccine Models, Specifications and Application
10.3.3 Aldevron Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Aldevron Company Profile and Main Business
10.3.5 Aldevron Recent Developments
10.4 Boehringer Ingelheim International GmbH
10.4.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
10.4.2 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Models, Specifications and Application
10.4.3 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Boehringer Ingelheim International GmbH Company Profile and Main Business
10.4.5 Boehringer Ingelheim International GmbH Recent Developments
10.5 Brammer Bio
10.5.1 Brammer Bio Company Information, Head Office, Market Area and Industry Position
10.5.2 Brammer Bio Viral Vector and Vaccine Models, Specifications and Application
10.5.3 Brammer Bio Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Brammer Bio Company Profile and Main Business
10.5.5 Brammer Bio Recent Developments
10.6 Charles River Laboratories
10.6.1 Charles River Laboratories Company Information, Head Office, Market Area and Industry Position
10.6.2 Charles River Laboratories Viral Vector and Vaccine Models, Specifications and Application
10.6.3 Charles River Laboratories Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Charles River Laboratories Company Profile and Main Business
10.6.5 Charles River Laboratories Recent Developments
10.7 Creative-Biogene
10.7.1 Creative-Biogene Company Information, Head Office, Market Area and Industry Position
10.7.2 Creative-Biogene Viral Vector and Vaccine Models, Specifications and Application
10.7.3 Creative-Biogene Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Creative-Biogene Company Profile and Main Business
10.7.5 Creative-Biogene Recent Developments
10.8 Fujifilm Corporation
10.8.1 Fujifilm Corporation Company Information, Head Office, Market Area and Industry Position
10.8.2 Fujifilm Corporation Viral Vector and Vaccine Models, Specifications and Application
10.8.3 Fujifilm Corporation Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Fujifilm Corporation Company Profile and Main Business
10.8.5 Fujifilm Corporation Recent Developments
10.9 General Electric
10.9.1 General Electric Company Information, Head Office, Market Area and Industry Position
10.9.2 General Electric Viral Vector and Vaccine Models, Specifications and Application
10.9.3 General Electric Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 General Electric Company Profile and Main Business
10.9.5 General Electric Recent Developments
10.10 MerckKGaA
10.10.1 MerckKGaA Company Information, Head Office, Market Area and Industry Position
10.10.2 MerckKGaA Viral Vector and Vaccine Models, Specifications and Application
10.10.3 MerckKGaA Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 MerckKGaA Company Profile and Main Business
10.10.5 MerckKGaA Recent Developments
10.11 Novasep
10.11.1 Novasep Company Information, Head Office, Market Area and Industry Position
10.11.2 Novasep Viral Vector and Vaccine Models, Specifications and Application
10.11.3 Novasep Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Novasep Company Profile and Main Business
10.11.5 Novasep Recent Developments
10.12 Pfizer
10.12.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.12.2 Pfizer Viral Vector and Vaccine Models, Specifications and Application
10.12.3 Pfizer Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Pfizer Company Profile and Main Business
10.12.5 Pfizer Recent Developments
10.13 Spark Therapeutics
10.13.1 Spark Therapeutics Company Information, Head Office, Market Area and Industry Position
10.13.2 Spark Therapeutics Viral Vector and Vaccine Models, Specifications and Application
10.13.3 Spark Therapeutics Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Spark Therapeutics Company Profile and Main Business
10.13.5 Spark Therapeutics Recent Developments
10.14 Thermo Fisher Scientific
10.14.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
10.14.2 Thermo Fisher Scientific Viral Vector and Vaccine Models, Specifications and Application
10.14.3 Thermo Fisher Scientific Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Thermo Fisher Scientific Company Profile and Main Business
10.14.5 Thermo Fisher Scientific Recent Developments
10.15 Waisman Biomanufacturing
10.15.1 Waisman Biomanufacturing Company Information, Head Office, Market Area and Industry Position
10.15.2 Waisman Biomanufacturing Viral Vector and Vaccine Models, Specifications and Application
10.15.3 Waisman Biomanufacturing Viral Vector and Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Waisman Biomanufacturing Company Profile and Main Business
10.15.5 Waisman Biomanufacturing Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Viral Vector and Vaccine Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Viral Vector and Vaccine Market Restraints
Table 3. Viral Vector and Vaccine Market Trends
Table 4. Viral Vector and Vaccine Industry Policy
Table 5. Global Viral Vector and Vaccine Revenue by Company, 2018-2023, US$ million
Table 6. Global Viral Vector and Vaccine Revenue Market Share by Company, 2018-2023
Table 7. Global Viral Vector and Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Viral Vector and Vaccine Sales Volume Market Share by Company, 2018-2023
Table 9. Global Viral Vector and Vaccine Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Viral Vector and Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Viral Vector and Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Viral Vector and Vaccine Manufacturers Product Type
Table 13. China Viral Vector and Vaccine Revenue by Company, 2018-2023, US$ million
Table 14. China Viral Vector and Vaccine Revenue Market Share by Company, 2018-2023
Table 15. China Viral Vector and Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Viral Vector and Vaccine Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Viral Vector and Vaccine Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Viral Vector and Vaccine Import & Export Trends
Table 19. Main Sources of China Viral Vector and Vaccine Import
Table 20. Export Destination of China Viral Vector and Vaccine
Table 21. Global Headquarters and Manufacturing Base of Viral Vector and Vaccine Manufacturers
Table 22. Global Major Manufacturers, Viral Vector and Vaccine Capacity Expansion and Future Plans
Table 23. Global Viral Vector and Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Viral Vector and Vaccine Production by Region, 2018-2023, (K Units)
Table 25. Global Viral Vector and Vaccine Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Viral Vector and Vaccine Upstream (Raw Materials)
Table 27. Global Viral Vector and Vaccine Typical Customers
Table 28. Viral Vector and Vaccine Typical Distributors
Table 29. By Type, Global Viral Vector and Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Viral Vector and Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Viral Vector and Vaccine Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Viral Vector and Vaccine Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Viral Vector and Vaccine Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Viral Vector and Vaccine Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Viral Vector and Vaccine Revenue Market Share, 2018-2029
Table 37. By Country, Global Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Viral Vector and Vaccine Sales Volume Market Share, 2018-2029
Table 39. ABL Company Information, Head Office, Market Area and Industry Position
Table 40. ABL Viral Vector and Vaccine Models, Specifications and Application
Table 41. ABL Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. ABL Company Profile and Main Business
Table 43. ABL Recent Developments
Table 44. Addgene Company Information, Head Office, Market Area and Industry Position
Table 45. Addgene Viral Vector and Vaccine Models, Specifications and Application
Table 46. Addgene Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Addgene Company Profile and Main Business
Table 48. Addgene Recent Developments
Table 49. Aldevron Company Information, Head Office, Market Area and Industry Position
Table 50. Aldevron Viral Vector and Vaccine Models, Specifications and Application
Table 51. Aldevron Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Aldevron Company Profile and Main Business
Table 53. Aldevron Recent Developments
Table 54. Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
Table 55. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Models, Specifications and Application
Table 56. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Boehringer Ingelheim International GmbH Company Profile and Main Business
Table 58. Boehringer Ingelheim International GmbH Recent Developments
Table 59. Brammer Bio Company Information, Head Office, Market Area and Industry Position
Table 60. Brammer Bio Viral Vector and Vaccine Models, Specifications and Application
Table 61. Brammer Bio Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Brammer Bio Company Profile and Main Business
Table 63. Brammer Bio Recent Developments
Table 64. Charles River Laboratories Company Information, Head Office, Market Area and Industry Position
Table 65. Charles River Laboratories Viral Vector and Vaccine Models, Specifications and Application
Table 66. Charles River Laboratories Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Charles River Laboratories Company Profile and Main Business
Table 68. Charles River Laboratories Recent Developments
Table 69. Creative-Biogene Company Information, Head Office, Market Area and Industry Position
Table 70. Creative-Biogene Viral Vector and Vaccine Models, Specifications and Application
Table 71. Creative-Biogene Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Creative-Biogene Company Profile and Main Business
Table 73. Creative-Biogene Recent Developments
Table 74. Fujifilm Corporation Company Information, Head Office, Market Area and Industry Position
Table 75. Fujifilm Corporation Viral Vector and Vaccine Models, Specifications and Application
Table 76. Fujifilm Corporation Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Fujifilm Corporation Company Profile and Main Business
Table 78. Fujifilm Corporation Recent Developments
Table 79. General Electric Company Information, Head Office, Market Area and Industry Position
Table 80. General Electric Viral Vector and Vaccine Models, Specifications and Application
Table 81. General Electric Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. General Electric Company Profile and Main Business
Table 83. General Electric Recent Developments
Table 84. MerckKGaA Company Information, Head Office, Market Area and Industry Position
Table 85. MerckKGaA Viral Vector and Vaccine Models, Specifications and Application
Table 86. MerckKGaA Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. MerckKGaA Company Profile and Main Business
Table 88. MerckKGaA Recent Developments
Table 89. Novasep Company Information, Head Office, Market Area and Industry Position
Table 90. Novasep Viral Vector and Vaccine Models, Specifications and Application
Table 91. Novasep Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Novasep Company Profile and Main Business
Table 93. Novasep Recent Developments
Table 94. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 95. Pfizer Viral Vector and Vaccine Models, Specifications and Application
Table 96. Pfizer Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Pfizer Company Profile and Main Business
Table 98. Pfizer Recent Developments
Table 99. Spark Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 100. Spark Therapeutics Viral Vector and Vaccine Models, Specifications and Application
Table 101. Spark Therapeutics Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Spark Therapeutics Company Profile and Main Business
Table 103. Spark Therapeutics Recent Developments
Table 104. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
Table 105. Thermo Fisher Scientific Viral Vector and Vaccine Models, Specifications and Application
Table 106. Thermo Fisher Scientific Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Thermo Fisher Scientific Company Profile and Main Business
Table 108. Thermo Fisher Scientific Recent Developments
Table 109. Waisman Biomanufacturing Company Information, Head Office, Market Area and Industry Position
Table 110. Waisman Biomanufacturing Viral Vector and Vaccine Models, Specifications and Application
Table 111. Waisman Biomanufacturing Viral Vector and Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Waisman Biomanufacturing Company Profile and Main Business
Table 113. Waisman Biomanufacturing Recent Developments
List of Figure
Figure 1. Viral Vector and Vaccine Picture
Figure 2. By Revenue, Global Viral Vector and Vaccine Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Viral Vector and Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Viral Vector and Vaccine Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Viral Vector and Vaccine Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Viral Vector and Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Viral Vector and Vaccine Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Viral Vector and Vaccine Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Viral Vector and Vaccine Share of Global Market, 2018-2029
Figure 10. Global Viral Vector and Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Viral Vector and Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Viral Vector and Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Viral Vector and Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Viral Vector and Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Viral Vector and Vaccine Domestic VS Export, 2022
Figure 16. Global Viral Vector and Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Viral Vector and Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Viral Vector and Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 19. Viral Vector and Vaccine Industry Chain
Figure 20. Viral Vector and Vaccine Procurement Model
Figure 21. Viral Vector and Vaccine Sales Model
Figure 22. Viral Vector and Vaccine Sales Channels, Direct Sales and Distribution
Figure 23. Adenovirus
Figure 24. Fowlpox Virus
Figure 25. Attenuated Yellow Fever
Figure 26. Vaccinia Virus Vectors
Figure 27. By Type, Global Viral Vector and Vaccine Revenue, 2018-2029, US$ Million
Figure 28. By Type, Global Viral Vector and Vaccine Revenue Market Share, 2018-2029
Figure 29. By Type, Global Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 30. By Type, Global Viral Vector and Vaccine Sales Volume Market Share, 2018-2029
Figure 31. By Type, Global Viral Vector and Vaccine Price, 2018-2029, (US$/Unit)
Figure 32. Research Institutes
Figure 33. Biopharmaceutical Companies
Figure 34. Others
Figure 35. By Application, Global Viral Vector and Vaccine Revenue, 2018-2029, US$ Million
Figure 36. By Application, Global Viral Vector and Vaccine Revenue Market Share, 2018-2029
Figure 37. By Application, Global Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 38. By Application, Global Viral Vector and Vaccine Sales Volume Market Share, 2018-2029
Figure 39. By Application, Global Viral Vector and Vaccine Price, 2018-2029, (US$/Unit)
Figure 40. By Region, Global Viral Vector and Vaccine Revenue Market Share, 2018-2029
Figure 41. By Region, Global Viral Vector and Vaccine Sales Volume Market Share, 2018-2029
Figure 42. North America Viral Vector and Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America Viral Vector and Vaccine Revenue Market Share, 2022
Figure 44. Europe Viral Vector and Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe Viral Vector and Vaccine Revenue Market Share, 2022
Figure 46. Asia Pacific Viral Vector and Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific Viral Vector and Vaccine Revenue Market Share, 2022
Figure 48. South America Viral Vector and Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America Viral Vector and Vaccine Revenue Market Share, 2022
Figure 50. Middle East & Africa Viral Vector and Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 52. By Company, U.S. Viral Vector and Vaccine Market Share, 2022
Figure 53. By Type, U.S. Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 54. By Application, U.S. Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 55. Europe Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, Europe Viral Vector and Vaccine Market Share, 2022
Figure 57. By Type, Europe Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, Europe Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 59. China Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, China Viral Vector and Vaccine Market Share, 2022
Figure 61. By Type, China Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, China Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 63. Japan Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, Japan Viral Vector and Vaccine Market Share, 2022
Figure 65. By Type, Japan Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, Japan Viral Vector and Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 67. South Korea Viral Vector and Vaccine Sales Volume, 2018-2029, (K Units)
Figure 68. By Company, South Korea Viral Vector and Vaccine Market Share, 2022
Figure 69. By Type, South Korea Vira
Research Methodology:
Global Viral Vector and Vaccine Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|